Cerium oxide nanocomplex and a composition for preventing or treating peritonitis comprising the same
US12303568B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2022 |
| Grant date | May 20, 2025 |
| Priority date | — |
| Expiry date | Jan 26, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A cerium oxide nanocomplex, a composition containing the cerium oxide nanocomplex as an active ingredient, and uses thereof for preventing or treating peritonitis are disclosed. The cerium oxide nanocomplex improves the biomedical stability, biocompatibility, and efficiency of the production process of nanoparticles while maintaining the excellent inhibitory activity against inflammation by applying a biocompatible polymer composed of an optimal combination. The cerium oxide nanocomplex may be used as an excellent therapeutic composition that may greatly improve patients' survival rate by effectively inhibiting inflammatory response and quickly blocking tissue damage at early stage of peritonitis when a radical inflammatory injury occurs because of the penetration of bacteria, foreign body and immune cells into a perforated organ in the abdominal cavity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.